[1] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[2] |
Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping.
Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(3): 303-307.
|
[3] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
[4] |
TANG Yijun, WANG Wenlong, LI Jiangli, YANG Huan, SUN Jing.
LncRNA RP11-686D22.10 is related with the survival of breast cancer patients, affects the proliferation, invasion of breast cancer cell lines
[J]. Basic & Clinical Medicine, 2023, 43(7): 1023-1029.
|
[5] |
JIN Xiaoxia, LU Xiaoyun, LIU Yushan, LIANG Lina.
Expression and clinical significance of SIRT2 in urothelial bladder cancer and its impact on cancer cell proliferation, invasion and migration
[J]. Basic & Clinical Medicine, 2023, 43(7): 1090-1096.
|
[6] |
ZENG Yankun, HONG Xiaoying, CHEN Qinglin.
Down-regulation of BECN1 inhibits the proliferation, invasion and migration of human leukemia cell line THP-1
[J]. Basic & Clinical Medicine, 2023, 43(7): 1104-1109.
|
[7] |
LENG Haina, ZHANG Yan, WANG Xiaodong, ZHANG Xueyou, LI Hongli.
miR-767-5p inhibits the invasion of ovarian cancer cell lines by regulating the expression of TBL1XR1 protein
[J]. Basic & Clinical Medicine, 2023, 43(3): 408-414.
|
[8] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|
[9] |
HOU Lijie, MA Chengxu, WANG Jingyu, TANG Xulei, FU Songbo.
LncRNA (HOTAIR) /miR-206/TAGLN2 signal axis regulates the invasion of papillarythyroid carcinoma cells
[J]. Basic & Clinical Medicine, 2023, 43(11): 1642-1647.
|
[10] |
NIE Dan, WANG Chunyan, LI Zhengyu.
Upregulated RAI2 inhibits migration and invasion of endometrial cancer cell lines HEC-1-A and KLE
[J]. Basic & Clinical Medicine, 2023, 43(10): 1537-1541.
|
[11] |
HE Jing, LI Yan, WANG Yan-feng, BAO Hui.
Up-expression of FABP4 promotes the proliferation and migration of endometrial cancer cell line HEC-1-A
[J]. Basic & Clinical Medicine, 2022, 42(9): 1356-1361.
|
[12] |
LI He-tong, REN Jing-jing, WANG Wen-hao, HAO Min.
Advances in the study of the role of estrogen and its receptor combined with HPV in cervical cancer microenvironment
[J]. Basic & Clinical Medicine, 2022, 42(9): 1438-1442.
|
[13] |
SHEN Yong-hua, WANG Jun-feng, CHENG Ze-xing, FENG Juan-juan.
Esculin inhibits the proliferation of human nasopharyngeal carcinoma cell line HNE-3
[J]. Basic & Clinical Medicine, 2022, 42(8): 1237-1242.
|
[14] |
DU Xue-mei, ZHANG Yun-mei, ZHOU Wen-ting, LYU Hong.
miR-655-3p targeting KIF20A inhibits migration and invasion of lung adenocarcinoma cell line A549
[J]. Basic & Clinical Medicine, 2022, 42(4): 599-606.
|
[15] |
SUN Quan-peng, FAN Chao, ZHAN De-xi, FAN Yi-ming, SUN Wei-feng.
Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B
[J]. Basic & Clinical Medicine, 2022, 42(3): 448-453.
|